Explore common Python backtesting pain points, including data quality issues, execution assumptions, and evaluation ...
Across the country, state lawmakers are considering ways to address the risks posed by the explosion of power-hungry data centers. They have proposed an array of bills to impose moratoriums on data ...
AI can now do most of the boring work, which raises the question of what the humans will be doing. According to vendors ...
In this week’s Crypto Long & Short Newsletter, Ruchir Gupta writes on how we’re moving toward a true fixed-income market for crypto-native yield. Then, Clara García Prieto on bitcoin becoming ...
In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free survival (rPFS) of 10.1 months and PSA50 response of 40%. Phase I Monotherapy ...
The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective strategies. Objectives: Provider organizations are increasingly entering ...
Third-party apps, aftermarket parts, and hidden settings can make your Peloton experience so much better.
Welcome to Comtech Telecommunications Corp.'s Conference Call for the Second Quarter of Fiscal 2026. As a reminder, this conference call is being recorded. I would now like to turn the call over to ...
Windows has always been built for power users who automate. Now, OpenClaw and cloud APIs like WayinVideo are ushering in a new era of truly autonomous desktop workflows — here's what that looks like ...
Dividend Declaration -- The Board declared a $0.42 per share dividend, representing a 9.8% annualized rate on ending book value.
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Good afternoon, and welcome to Arthur J. Gallagher & Company's quarterly investor meeting with management. [Operator Instructions] Today's call is being recorded. If you have any objections, you may ...